SCHEMBL22776019

SCHEMBL22776019

COc1ccc(CN2CCn3nnnc3C2c2ccc(F)cc2)c(OC)c1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16830487 0.90 RORC (1.00) RORC
SCHEMBL16830552 0.85 RORC (1.00) RORC
SCHEMBL16830485 0.81 RORC (1.00) RORC
SCHEMBL16830547 0.81 RORC (1.00) RORC
SCHEMBL22784485 0.78 RORC (0.51) RORC
SCHEMBL16830644 0.78 RORC (1.00) RORC
SCHEMBL16830683 0.77 RORC (1.00) RORC
SCHEMBL16830512 0.77 RORC (1.00) RORC
SCHEMBL16830503 0.76 RORC (1.00) RORC
SCHEMBL16830510 0.76 RORC (1.00) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113950477-B Granulin precursor modulators and methods of use thereof 阿库达医疗公司 2024-07-05 CN disclosed
EP-3983401-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME Arkuda Therapeutics (US) 2022-04-20 EP disclosed
WO-2020252222-A1 PROGRANULIN MODULATORS AND METHODS OF USING THE SAME ARKUDA THERAPEUTICS (US) 2020-12-17 WO disclosed